Site-specific effects of the nonsteroidal anti-inflammatory drug lysine clonixinate on rat brain opioid receptors

Pharmacology

Volumn 58, Issue 4, 1999, Pages 190-199

  Ortí, Eduardo ^a,b   Coirini, Héctor ^c   Pico, José Carlos ^a  

^a Inst Farmacol y Toxicol Roemmers   (Argentina)

^b Pavon 2885   (Argentina)

^c NONE

Author keywords

Analgesics; Anti inflammatory drugs; Autoradiography; Brain; Clonixinate; Nonsteroidal anti inflammatory drugs; Opioid receptors

Indexed keywords

CLONIXIN LYSINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN MEMBRANE; BRAIN SLICE; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARIETAL LOBE; PRIORITY JOURNAL; RAT; THALAMUS NUCLEUS;

EID: 0032982235     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028281     Document Type: Article

References (42)

1. Forster C, Magerl W, Beck A, Geisslinger T, Gall T, Brune K, Handwerker HO: Differential effects of dipyrone, ibuprofen and paracetamol on experimentally induced pain in man. Agents Actions 1992;35: 112-121.
2. Brune K, Menzel-Soglowek S, Zeilhofer HU: Differential analgesic effects of aspirin-like drugs. Drugs 1992;44(suppl 5):52-59.
3. McCormack K, Brune K: Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. Drugs 1991;41:533-547.
4. Chu P, Murray S, Lissin D, von Zastrow M: Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J Biol Chem 1997;272: 27124-27130.
5. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971;231:232-235.
6. Vane JR, Botting RM: Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104(suppl):2-8.
7. Fosslien E: Adverse effects of non-steroidal anti-inflammatory drugs on the gastrointestinal system. Ann Clin Lab Sci 1998;28:67-81.
8. Ferreira SH, Lorenzetti BB, Corrêa FMA: Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 1978;53:39-48.
9. Sacerdote P, Monza G, Mantegazza P, Panerai A: Diclofenac and pirprofen modify pituitary and hypothalamic beta-endorphin concentrations. Pharmacol Res Commun 1985;17:679-684.
10. Jurna I, Brune K: Central effect of the non-steroid anti-inflammatory agents indometacin, ibuprofen and diclofenac determined in c fibre-evoked activity in single neurones of the rat thalamus. Pain 1990;41:71-80.
11. Bannwarth B, Demotes-Mainard F, Schaeverbeke T, Labat L, Dehais J: Central analgesic effects of aspirin-like drugs. Fundam Clin Pharmacol 1995;9:1-7.
12. Sandrini M, Vitale G, Dondi M, Pini LA: Effects of acetylsalicylic acid on serotonin brain receptor subtypes. Gen Pharmacol 1995;26: 737-741.
13. Bustamante D, Paeile C, Willer J-C, Le Bars D: Effects of intravenous nonsteroidal antiinflammatory drugs on a c-fiber reflex elicited by a wide range of stimulus intensities in the rat. J Pharmacol Exp Ther 1996; 276:1232-1243.
14. Troullos E, Hargreaves KM, Dionne RA: Ibuprofen elevates immunoreactive beta-endorphin levels in humans during surgical stress. Clin Pharmacol Ther 1997;62:74-81.
15. Pini LA, Sandrini M, Vitale G: The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol 1996;308:31-40.
16. Gropetti A, Braga PC, Biella G, Parenti M, Rusconi L, Mantegazza P: Effect of aspirin on serotonin and Met enkephalin in brain: Correlation with the antinociceptive activity of the drug. Neuropharmacology 1988;27:499-505.
17. Brune K: Spinal cord effects of anti-pyretic analgesics. Drugs 1994; 47(suppl 5):21-27.
18. Vescovi P, Passeri M, Gerra G, Grossi E: Naloxone inhibits the early phase of diclofenac analgesia in man. Pain Clin 1987;1:151-155.
19. Domer F: Characterization of the analgesic activity of ketorolac in mice. Eur J Pharmacol 1990;177: 127-135.
20. Björkman R, Hedner J, Hedner T, Henning M: Central, naloxone-reversible antinociception by diclofenac in the rat. Naunyn Schmiedeberg Arch Pharmacol 1990;342:171-176.
21. Martini A, Bondiolotti GP, Sacerdote P, Pierro L, Picotti GB, Panerai AE, Restelli L, Zancaner F, Monza G: Diclofenac increases beta-endorphin plasma concentrations. J Int Med Res 1984;12:92-95.
22. Marti ML, De los Santos AR, Di Girolamo G, Gil M, Maner EO, Fraga C: Lysine clonixinate in minor dental surgery: Double-blind randomized parallel study versus paracetamol. Int J Tissue React 1993;15: 207-213.
23. Osswald M, Frerick H, Maisenbacher J, Schenk N, Grabner P: Schmerzbehandlung nach Weisheitszahnextraktion: Randomisierte Doppelblindstudie Clonixin-Lysinat versus Ibuprofen. ZWR 1994; 103:381-384.
24. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. New York, Academic Press, 1982.
25. Gulya K, Gehlert DR, Wamsley JK, Mosberg HI, Hruby VJ, Duckles SP, Yamamura HI: Autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog. Eur J Pharmacol 1985;111:285-286.
26. 3H]bremazocine. Neuroscience 1986;19:839-846.
27. Rasband WS, Bright DS: NIH Image: A public domain image processing for the Macintosh. Microbeam Anal Soc J 1995;4:137-149.
28. Hurlbut DE, Evans CJ, Barchas JD, Leslie FM: Pharmacological properties of a proenkephalin A-derived opioid peptide: BAM 18. Eur J Pharmacol 1987;138:359-366.
29. Bagley JR, Thomas SA, Rudo FG, Spencer HK, Doorley BM, Ossipov MH, Jerussi TP, Benvenga MJ, Spaulding T: New 1(heterocyclylalkyl)-4-(propionanilido)-4-piperidinyl methyl ester and methylene methyl ether analgesics. J Med Chem 1991;34:827-841.
30. Leslie FM: Methods used for the study of opioid receptors. Pharmacol Rev 1987;39:197-249.
31. Mosberg HI, Omnaas JR, Goldstein A: Structural requirements for delta opioid receptor binding. Mol Pharmacol 1987;31:599-602.
32. Simmons ML, Chavkin C: Endogenous opioid regulation of hippocampal function. Int Rev Neurobiol 1996;39:145-196.
33. Zukin RS, Tempel A: Neurochemical correlates of opiate receptor regulation. Biochem Pharmacol 1986; 35:1623-1627.
34. Morris BJ, Millan MJ, Herz A: Antagonist-induced opioid receptor upregulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. J Pharmacol Exp Ther 1988;247:729-736.
35. Belcheva MM, Barg J, McHale RJ, Gao X-M, Chuang D-M, Coscia C: Upregulation of delta opioid receptors in neuroblastoma hybrid cells: Evidence for differences in the mechanisms of action of sodium butyrate and naltrexone. J Pharmacol Exp Ther 1991;259:302-309.
36. Yoburn BC, Billings B, Duttaroy A: Opioid receptor regulation in mice. J Pharmacol Exp Ther 1993;265: 314-320.
37. 3H]cydoFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramine. J Pharm Pharmacol 1989;41:865-867.
38. Hamon M, Gozlan H, Bourgoin S, Benoliel JJ, Taquet H, Cesselin F, Mico JA: Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline. Neuropharmacology 1987;26:531-539.
39. Charness ME, Querimit LA, Diamond I: Ethanol increases the expression of functional delta-opioid receptors in neuroblastoma x glioma NG108-15 hybrid cells. J Biol Chem 1986;261:3164-3169.
40. Weiland NG, Wise PM: Estrogen and progesterone regulate opiate receptor densities in multiple brain regions. Endocrinology 1990;126: 804-808.
41. Goodman CB, Emilien B, Beckets K, Cadet JL, Rothman RB: Down-regulation of mu-opioid binding sites following chronic administration of neuropeptide FF(NPFF) and morphine. Peptides 1996;17:389-397.
42. Delfs JM, Yu L, Ellison GD, Reissine T, Chesselet MF: Regulation of mu-opioid receptor mRNA in rat globus pallidus: Effects of enkephalin increases induced by short- and long-term haloperidol administration. J Neurochem 1994;63:777-780.